ライフサイエンスコーパス: guideline

1 nths (Botswana guidelines) or 12 months (WHO guidelines).

2 e mineral density is beyond the scope of the guideline.

3 ents (39.8% female) after publication of the guideline.

4 lects changes in evidence since the previous guideline.

5 ystematic Reviews and Meta-Analyses (PRISMA) guideline.

6 nt Task Force reviewed before finalizing the guideline.

7 re and after publication of the 2013 ACC/AHA guideline.

8 methodology and evidence model used by each guideline.

9 o AD was carried out according to the PRISMA guidelines.

10 ing strategy, in line with clinical practice guidelines.

11 or diagnostic workup and supported by recent guidelines.

12 nostic accuracy, and evidence-based clinical guidelines.

13 on National Heart, Lung, and Blood Institute guidelines.

14 ts were evaluated according to international guidelines.

15 College of Medical Genetics (ACMG) consensus guidelines.

16 bservational Studies in Epidemiology (MOOSE) guidelines.

17 e, and most resolved with established safety guidelines.

18 and after 2010 cardiopulmonary resuscitation guidelines.

19 range of 37-185 MBq as recommended incurrent guidelines.

20 ress, testing remained far below recommended guidelines.

21 y strictly adhering to existing AC screening guidelines.

22 e using icatibant at a frequency above label guidelines.

23 d with genetic test results based on current guidelines.

24 ceeded World Health Organization air quality guidelines.

25 HIV/STI screening recommendations in the CDC guidelines.

26 n excess initial doses according to the 2016 guidelines.

27 tudy screening process adhered to the PRISMA Guidelines.

28 o treatment advocated by the WHO therapeutic guidelines.

29 heir effectiveness or international clinical guidelines.

30 s in ICS households still remained above WHO guidelines.

31 2016 USPSTF recommendations vs 2013 ACC/AHA guidelines.

32 ritish Society of Antimicrobial Chemotherapy guidelines.

33 ed clinicians and according to institutional guidelines.

34 the October 29, 2013, announcement of the CW guidelines.

35 Few comprehensively implemented guidelines.

36 ems for Systematic Reviews and Meta-Analyses guidelines.

37 nder full implementation of the 2013 ACC/AHA guidelines.

38 providers' adherence to evidence-based care guidelines.

39 th Africa had moved swiftly to implement WHO guidelines (2004-2013) and had achieved high levels of A

40 in accordance with American Thoracic Society guidelines, 2005 (off-line excluded); reported/allowed c

41 tiative for Chronic Obstructive Lung Disease guidelines, 461 patients (17.6%) had mild, 1,452 (55.5%)

42 he preferred learning modalities were online guidelines (69.6%) and courses (68.8%) followed closely

43 of popular pet foods sold in the UK with EU guidelines (94% and 61% of wet and dry foods, respective

44 A majority of foods complied with >/=8 of 11 guidelines (99% and 83% for dry and wet food, respective

45 ASCO endorsed the ACS HNC Survivorship Care Guideline, adding qualifying statements aimed at promoti

46 To determine the association of guideline adherence with clinical outcomes in patients w

47 Children treated with guideline-adherent antibiotics had lower 30-day ACS-rela

48 for ACS and to determine whether receipt of guideline-adherent antibiotics was associated with lower

49 Guideline-adherent antibiotics were provided in 10654 of

50 This guideline aims to give practical advice on performing ve

51 ONS: We here evaluate allergen immunotherapy guideline (AIT-GL) quality.

52 Since 1988, numerous allergen immunotherapy guidelines (AIT-GLs) have been developed by national and

53 This protocol, plus accompanying guidelines, allows researchers from students to imaging

54 ril 1, 2015) publication of the 2013 ACC/AHA guideline among 4 mutually exclusive risk groups within

55 nts (40.2% female) before publication of the guideline and 70.0 (11.9) years among 1116472 patients (

56 adults using criteria from the 2017 ACC/AHA guideline and the Seventh Report of the Joint National C

57 The development of this Guideline and use in the Czech Republic is described and

58 treatment of hyponatremia, comparing the two guidelines and highlighting recent developments.

59 nstitutional level can increase adherence to guidelines and may improve patient outcomes.

60 This problem requires changes to prescribing guidelines and patient counseling during the surveillanc

61 Guidelines and position papers indicate that allergen im

62 essential information for cervical screening guidelines and public health policy.

63 Such resolution meets the international guidelines and recommendations (15ng/mL) for diagnostic

64 e recent steam electric effluent limitations guidelines and standards (ELGs) since the U.S. EPA analy

65 n is available at www.asco.org/breast-cancer-guidelines and www.asco.org/guidelineswiki .

66 horacic Society/European Respiratory Society guidelines) and NONSA after intramuscular triamcinolone

67 n excess initial doses according to the 2011 guidelines, and 47% of the patients had been placed on e

68 tematic search was conducted based on PRISMA guidelines, and a meta-analysis was performed using the

69 Smoking, not meeting physical activity guidelines, and being either underweight or obese were a

70 Cutoff values, guidelines, and clinical recommendations for iFR can the

71 role in clinical decision making, treatment guidelines, and health policy.

72 f recommendations, methodological quality of guidelines, and the quality of evidence supporting each

73 on to monitor the appropriateness of therapy guidelines, antibiotic formulary, antibiotic stewardship

74 The ASCO guideline approval body, the Clinical Practice Guideline

75 National Comprehensive Cancer Network (NCCN) guideline-approved targeted drugs.

76 As a small number of dietary guidelines are beginning to incorporate more general env

77 testinal bleeds by 70-90%, uptake is low and guidelines are conflicting.

78 the need for healthcare providers to ensure guidelines are followed when performing venepuncture, eq

79 These guidelines are intended to improve the clarity of scient

80 However, evidence-based guidelines are lacking, and there is no consensus regard

81 Purpose Guidelines are limited for genetic testing for prostate

82 Design guidelines are presented to facilitate further research

83 mination and implementation of SCD treatment guidelines are warranted as is comparative effectiveness

84 s principles for the development of clinical guidelines as the framework for guideline development.

85 sicians reported limited training and use of guideline assessment, whereas most supported a campaign

86 : Recommendations for Interventional Trials) guideline authors (n = 16), pharmaceutical industry stat

87 to record financial payments received by 49 guideline authors using the Open Payments database.

88 xacerbations in the fall period treated with guidelines-based therapy (GBT) in the absence and presen

89 gement was based on (1) national recommended guidelines (baseline period [January 1, 2010, through No

90 No guidelines can take into account all of the often compel

91 In the evidence review conducted for the guideline, cardiovascular disease mortality and colorect

92 dical literature on observed deviations from guidelines, clinical significance, and initiatives to im

93 ement, and genetics were retrieved (reviews, guidelines, clinical trials, case series), and their bib

94 mended in the European Society of Cardiology guideline combining LOD and 1-hour algorithm.

95 ideline approval body, the Clinical Practice Guidelines Committee, approved the final endorsement.

96 TCT) rate at 12 months of 4.9%; we simulated guideline-concordant rates of testing uptake, result ret

97 dated the literature search and reviewed the guideline content and recommendations.

98 e whether a novel, 2-part, clinical practice guideline could decrease the rates of total blood cultur

99 s in the light of new data to assess whether guidelines could be improved.

100 al cost-effectiveness of a clinical practice guideline (CPG) compared with "usual care" for treatment

101 nt AC screening despite not meeting existing guideline criteria, 21% and 10%, respectively, were foun

102 Most clinicians do not adhere to IDSA guidelines, delaying diagnostic LP and increasing costs.

103 rialists, systematic reviewers, and clinical guideline developers), and patient representatives produ

104 he Institute of Medicine (IOM) standards for guideline development have had unintended negative conse

105 plinary team of 29 members with expertise in guideline development, evidence analysis, and family-cen

106 , to validate the process and outcome of the guideline development.

107 of clinical guidelines as the framework for guideline development.

108 nt care, and those establishing policies for guideline development.

109 While statin-eligible individuals by USPSTF guidelines did not have a significantly higher 10-year A

110 LCZ696 [200 mg twice daily]) in addition to guideline-directed medical therapy.

111 Conclusion SRU consensus guidelines effectively stratified the risk of neoplasia

112 ns specified in the 2015 Effluent Limitation Guidelines (ELGs).

113 disparities and variation in CRT-D use among guideline-eligible patients may improve patient outcomes

114 left ventricular function, current practice guidelines empirically recommend serial evaluations ever

115 individuals indicated for statins under both guidelines experienced 9.6 cardiovascular events per 100

116 nd modifications were added to adapt the CCO guideline for a broader audience.

117 Objectives To establish an evidence-based guideline for HER2 testing in patients with GEA, formali

118 results provide a theoretical and empirical guideline for predicting the ethanol concentration in co

119 gy (ASCO)-Society of Surgical Oncology (SSO) guideline for sentinel lymph node (SLN) biopsy in melano

120 This case offers a guideline for the clinical management towards survival o

121 care (control group), according to national guidelines for 18 months, or decentralised care plus str

122 s (intervention group) according to national guidelines for 18 months.

123 ent with the World Health Organization (WHO) Guidelines for Accurate and Transparent Health Estimates

124 Chemical guidelines for achieving the targeted compounds are pres

125 supplements on the basis of the 2015 Dietary Guidelines for Americans and derived from a 137-item sel

126 tute for Health and Care Excellence clinical guidelines for anxiety, depression, and OA and was suppo

127 Guidelines for cancer genetic testing based on family hi

128 The WHO issued guidelines for DBAN after it was linked with cancer of t

129 As each screen is unique, we provide guidelines for determining screening parameters and main

130 Therapeutic guidelines for empirical treatment of common life-threat

131 Our work provides general guidelines for engineering electromagnetic illusions but

132 This Perspective's summary features guidelines for exploiting water molecules in drug discov

133 Administration published new, more stringent guidelines for glucose meter manufacturers to evaluate t

134 ritical Care Medicine provided 2002 and 2007 guidelines for hemodynamic support of newborn and pediat

135 Guidelines for investigation of perioperative drug aller

136 In reaction, guidelines for journals have been promulgated and grant

137 id strata using National Cholesterol Program guidelines for lipid strata.

138 iew the literature and create joint national guidelines for managing asthma, reflecting this heteroge

139 establishing comprehensive and standardized guidelines for multi-site studies.

140 viral pathogenicity in honey bee larvae, and guidelines for OSS use may be warranted.

141 Clinical management guidelines for patients with germline mutations in these

142 The development of evidence-based treatment guidelines for pediatric pulmonary arterial hypertension

143 density-functional theory to uncover design guidelines for predicting noncentrosymmetric compounds,

144 in the field, aiming to (1) propose general guidelines for predictive analytics projects in psychiat

145 sed guideline quality using the Appraisal of Guidelines for Research and Evaluation, 2nd edition (AGR

146 essional organizations have offered clinical guidelines for review and return of prioritization resul

147 ed care to revise the 2007 Clinical Practice Guidelines for support of the family in the patient-cent

148 Guidelines for surveillance and management of potential

149 All methods followed the PRISMA Reporting Guidelines for systematic reviews of the literature.

150 hology (AMP) published updated standards and guidelines for the clinical interpretation of sequence v

151 s, led the development of the first clinical guidelines for the diagnosis and management of food alle

152 ake-sleep states of mice, and provide formal guidelines for the latter.

153 There are currently no guidelines for the management of infection and its preve

154 The development of consensus guidelines for this disease offers a framework for conti

155 Tissue residue guidelines for wildlife protection based on lake trout a

156 Disorder." The evidence review done for the guideline found no statistically significant difference

157 ntion Outcomes Network (ACTION)-Get With the Guidelines from April 1, 2011, through December 31, 2012

158 n this setting that included recent clinical guidelines from professional societies supplemented by r

159 The 2013 cholesterol management guidelines from the American College of Cardiology and A

160 on of prior pain management practices (e.g., guidelines from the Centers for Disease Control and Prev

161 Current guidelines give a class I recommendation to use of embol

162 This guideline grades the evidence and recommendations by usi

163 This guideline grades the evidence and recommendations using

164 This guideline grades the recommendations by using the GRADE

165 dividuals not eligible for statins by USPSTF guidelines had a higher ASCVD event rate in the presence

166 ed by linking patients from the Get With the Guidelines Heart Failure registry with Medicare data.

167 Observational analysis of Get With The Guidelines-HF registry participants who were admitted fo

168 ment strategies (ATSs)-longitudinal practice guidelines highly tailored to time-varying attributes of

169 To examine adoption of the 2013 ACC/AHA guideline in US cardiology practices.

170 eviews and integrated into clinical practice guidelines in several countries.

171 tional and national legislation, policy, and guidelines in the context of existing infection risks an

172 An expert panel reviewed current guidelines in the light of new data to assess whether gu

173 et Audience and The target audience for this guideline includes all clinicians, and the target patien

174 The 2013 ACC/AHA guidelines increase statin eligibility most among adults

175 ount (intervention) or according to national guidelines (initially </=350 cells per muL and <500 cell

176 ers, editors and funders to put experimental guidelines into practice.

177 This guideline is endorsed by the American Academy of Family

178 suggest that adherence to clinical practice guidelines is particularly challenging for racial minori

179 Currently, major guidelines make no definite statement about postoperativ

180 Planar HMR was calculated as per standard guidelines (manual traditional method) and elliptic regi

181 ic availability of atorvastatin, and updated guidelines may have resulted in a change in high-intensi

182 the American Heart Association Get With The Guidelines-Medical Emergency Team database between 2005

183 ematic reviews and 2 evidence-based clinical guidelines met inclusion criteria.

184 r multi-use to be acceptable, evidence based guidelines must be available for healthcare professional

185 and 11 mmol/L respectively according to the guideline of WHO.

186 Bauer Disk diffusion method according to the guidelines of Clinical and Laboratory Standard Institute

187 6 months to 3 years, as defined by the 2013 guidelines of the American Association for Pediatric Oph

188 than strategies in current clinical imaging guidelines, of which European ones primarily recommend C

189 ll children and to examine the effect of the guideline on patient outcomes.

190 Methods The ASTRO guideline on radiation therapy for glioblastoma was revi

191 Oncology (ASTRO) produced an evidence-based guideline on radiation therapy for glioblastoma.

192 Oncology (ASTRO) produced an evidence-based guideline on radiation therapy in oropharyngeal squamous

193 effort to update existing clinical practice guidelines on cholesterol, blood pressure, and overweigh

194 T, there are still no current evidence-based guidelines on its necessity and use for periodontal trea

195 tigations are required to best inform future guidelines on NMD-specific cardiovascular health risks,

196 he WHO definition of unsafe abortion and WHO guidelines on safe abortion to categorise abortions as s

197 To systematically review guidelines on sugar intake and assess consistency of rec

198 nt provides evidence-based clinical practice guidelines on the use of mechanical ventilation in adult

199 Comprehensive guidelines on use of everolimus (EVR) in LT are still la

200 gned to breastfeeding for 6 months (Botswana guidelines) or 12 months (WHO guidelines).

201 2008 Modified International Workshop on CLL guidelines) or small lymphocytic lymphoma were eligible

202 The national and international guidelines outline the principles of treatment.

203 e., clinical, radiologic, or serologic), the guideline panel made conditional recommendations against

204 his study is applicable to clinical practice guideline panels drafting recommendations, physicians us

205 he forthcoming Preferred Practice Pattern(R) guideline (PPP) Refractive Errors & Refractive Surgery i

206 es primarily recommend CXR/MRI, whereas U.S. guidelines preferably point to CHCT/MRI in patients with

207 when commonly practiced deviations from the guideline procedure were performed.

208 mple haemolysis, compared to the recommended guideline procedure.

209 In the surgically focused interpretation of guidelines, proportions of any neoplasm and malignant ne

210 International guidelines provide conflicting recommendations on how to

211 reatment options are available, but existing guidelines provide inconsistent advice on which treatmen

212 le for tOPV disposal and describe the global guidelines provided to countries for the safe and approp

213 The guideline provides information on factors other than sta

214 The European Association for Neuro-Oncology guideline provides recommendations for the clinical care

215 Three American Academy of Dermatology guidelines published from 2013 to 2016 were retrieved.

216 etermined that the ACS HNC Survivorship Care Guideline, published in 2016, is clear, thorough, clinic

217 tion: Three reviewers independently assessed guideline quality using the Appraisal of Guidelines for

218 Even though international guidelines recommend azithromycin as first-line treatmen

219 Current guidelines recommend five to six, which is impractical.

220 Current guidelines recommend genotype resistance testing at diag

221 All recent treatment guidelines recommend integrase strand transfer inhibitor

222 Guidelines recommend noninvasive testing for patients wi

223 erosclerotic cardiovascular disease (ASCVD), guidelines recommend optimizing statin treatment, and co

224 Heart failure guidelines recommend routine monitoring of serum potassi

225 Current guidelines recommend screening eye examinations for infa

226 International resuscitation guidelines recommend targeted temperature management (TT

227 Current guidelines recommend that all sexually active human immu

228 Current guidelines recommend use of natriuretic peptides (N-term

229 Clinical guidelines recommend using Kidney Disease Improving Glob

230 The evidence and guideline recommendations consistently support a clinica

231 Guideline recommendations for oral anticoagulants in AF

232 INTERPRETATION: The INTREPID results support guideline recommendations for pitavastatin as a preferre

233 n routine use of EPD, and meanwhile, current guideline recommendations on EPD use should be revisited

234 Purpose To update the guideline recommendations on the use of larynx-preservat

235 Whether existing cardio-oncology or imaging guideline recommendations will provide increased value o

236 ived care that differed in some respect from guideline recommendations.

237 ilable in many Ebola Treatment Units (ETUs), guidelines recommended empirical malaria treatment.

238 hich may affect the benefit-to-risk ratio of guideline-recommended antithrombotic therapies in differ

239 h known history of AF who were not receiving guideline-recommended antithrombotic treatment before st

240 ondition often considered benign and without guideline-recommended treatments.

241 These findings support guidelines recommending tenofovir alafenamide-based regi

242 um limits, development and implementation of guidelines regarding nutrient recommendations and estima

243 th disorders of consciousness and to provide guidelines regarding the number of assessments required

244 Intervention Outcomes Network)-Get With The Guidelines Registry for quarterly Mission: Lifeline repo

245 goal according to the 2017 ACC/AHA and JNC7 guidelines, respectively.

246 he American Heart Association's Get With the Guidelines-Resuscitation registry from January 1, 2000,

247 In this cohort study from Get With the Guidelines-Resuscitation, performed from January 1, 2000

248 We suggest that guidelines should be revised to indicate that later asse

249 ihood of causality assessment by established guidelines, six variants were classified as "pathogeneti

250 Despite recognition, international consensus guidelines specifically addressing the diagnosis and man

251 Results Twenty-one guideline statements (eight recommendations, 10 expert c

252 hospitals participating in the Get With the Guidelines-Stroke program.

253 the American Heart Association Get With The Guidelines-Stroke Registry, we examined the outcomes of

254 Since the 2000 guidelines, studies have provided evidence to support an

255 suggests that children undercorrected using guidelines suggested by Enyedi and associates may achiev

256 about the public policy recommendations and guidelines that are the intended result of collecting th

257 These findings support professional guidelines that recommend the use of ICDs in such patien

258 In this article, we offer guidelines that we hope will steer researchers toward be

259 ional Collaboration for Transfusion Medicine Guidelines (the use of leukoreduction and platelet trans

260 According to the 2017 ACC/AHA and JNC7 guidelines, the crude prevalence of hypertension among U

261 To inform these clinical guidelines, the current technical review was developed i

262 ccording to the 2012 International Consensus Guidelines, the diagnostic criterion of intraductal papi

263 ican College of Physicians recently issued a guideline titled "Nonpharmacologic Versus Pharmacologic

264 an Expert Panel to develop an evidence-based guideline to help establish standard molecular biomarker

265 n College of Physicians (ACP) developed this guideline to present the evidence and provide clinical r

266 evelopment of primary care interpretation of guidelines to aid patient selection, establishment of di

267 imaging expertise in accordance with current guidelines to assess the interobserver variability of FC

268 ety of American considers adherence to these guidelines to be voluntary, with the ultimate determinat

269 ial molecular quantum bits, and enriches the guidelines to design molecule-based systems with enhance

270 on limits across MPI publications we propose guidelines to improve the comparability of future MPI st

271 ndations, physicians using clinical practice guidelines to inform patient care, and those establishin

272 el viraemia need to be incorporated into WHO guidelines to meet UNAIDS-defined targets aimed at halti

273 ental Panel on Climate Change (IPCC) Tier II guidelines to quantify the evolution of CH4 emissions fr

274 Results The guideline update reflects changes in evidence since the

275 Results This guideline update reflects changes in evidence since the

276 lects changes in evidence since the previous guideline update.

277 Description: This guideline updates the 2008 American College of Physician

278 nduced AA and AR, their effect on subsequent guideline updates will depend on the methodology and evi

279 s ASCO uses a signals approach to facilitate guideline updates.

280 Clinical guidelines vary with respect to the optimal monitoring f

281 Statin recommendation under both guidelines was associated with a CAC score greater than

282 g 2RDA for protein compared with the current guidelines was found to have beneficial effects on lean

283 6 to 0.7, the discriminative ability of both guidelines was mediocre.

284 Following PRISMA guidelines, we searched multiple databases on Sept 1, 20

285 Following PRISMA guidelines, we systematically searched Embase, PsycINFO

286 To provide design guidelines, we use quantum mechanics to predict the deta

287 by IOM-compliant pulmonary or critical care guidelines were addressed by expert panels using a modif

288 nt-years, those indicated under only ACC/AHA guidelines were at low to intermediate risk (4.1 events

289 Therefore, guidelines were developed by professional organizations,

290 sis of Observational Studies in Epidemiology guidelines were followed.

291 Although specific, current guidelines were poorly sensitive, identifying only 34% t

292 International acute kidney injury and CKD guidelines were reportedly accessible in 52 (45%) and 62

293 The 2002 and 2007 guidelines were widely disseminated, translated into Spa

294 atic reviews or meta-analyses, and 5 reviews/guidelines) were selected for this review.

295 Implementation of the CDC PrEP guidelines while scaling up PrEP coverage could result i

296 This guideline will allow consistent conduct, interpretation,

297 These guidelines will be updated periodically as more evidence

298 Herein, we discuss how implementation of NIH guidelines will help investigators proactively address p

299 48) had HF care in accordance with published guidelines, with emphasis on titration of proven neuroho

300 d by antimicrobial stewardship program (ASP) guidelines, yet few studies have systematically evaluate